Tezacitabine
Hivid, Dacogen (tezacitabine) is a small molecule pharmaceutical. Tezacitabine was first approved as Hivid on 1992-06-19. It has been approved in Europe to treat myeloid leukemia.
Trade Name | Dacogen |
---|---|
Common Name | Tezacitabine |
Indication | myeloid leukemia |
Drug Class | Nucleoside antiviral or antineoplastic agents, cytarabine or azarabine derivatives |